These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Global Advisory Committee on Vaccine Safety, 11-12 June 2014. Wkly Epidemiol Rec; 2014 Jul; 89(29):325-35. PubMed ID: 25045773 [No Abstract] [Full Text] [Related]
4. Perspectives of vaccination against hepatitis E. Safary A Intervirology; 2001; 44(2-3):162-6. PubMed ID: 11509877 [TBL] [Abstract][Full Text] [Related]
5. Hepatitis: Hepatitis E vaccination--is HEV 239 the breakthrough? Wedemeyer H; Pischke S Nat Rev Gastroenterol Hepatol; 2011 Jan; 8(1):8-10. PubMed ID: 21212772 [No Abstract] [Full Text] [Related]
6. [Hepatitis E: an emerging viral disease]. Soriano V; Barreiro P Med Clin (Barc); 2014 Jul; 143(1):22-4. PubMed ID: 24656852 [No Abstract] [Full Text] [Related]
9. Hepatitis E-related adverse pregnancy outcomes and their prevention by hepatitis E vaccine in a rabbit model. Li M; Li S; He Q; Liang Z; Wang L; Wang Q; Wang L Emerg Microbes Infect; 2019; 8(1):1066-1075. PubMed ID: 31339458 [TBL] [Abstract][Full Text] [Related]
10. A Recombinant HAV Expressing a Neutralization Epitope of HEV Induces Immune Response against HAV and HEV in Mice. Xiang K; Kusov Y; Ying G; Yan W; Shan Y; Jinyuan W; Na Y; Yan Z; Hongjun L; Maosheng S Viruses; 2017 Sep; 9(9):. PubMed ID: 28914805 [TBL] [Abstract][Full Text] [Related]
11. Hepatitis E vaccine: not a moment too soon. Holmberg SD Lancet; 2010 Sep; 376(9744):849-51. PubMed ID: 20728933 [No Abstract] [Full Text] [Related]
12. Lessons from hepatitis E vaccine design. Li S; Zhang J; Xia N Curr Opin Virol; 2015 Apr; 11():130-6. PubMed ID: 25913817 [TBL] [Abstract][Full Text] [Related]
13. Toward the development of a hepatitis E vaccine. Kamili S Virus Res; 2011 Oct; 161(1):93-100. PubMed ID: 21620908 [TBL] [Abstract][Full Text] [Related]
14. Progress in the Production of Virus-Like Particles for Vaccination against Hepatitis E Virus. Mazalovska M; Kouokam JC Viruses; 2020 Jul; 12(8):. PubMed ID: 32751441 [TBL] [Abstract][Full Text] [Related]
16. Hepatitis E virus. Abravanel F; Lhomme S; Dubois M; Peron JM; Alric L; Kamar N; Izopet J Med Mal Infect; 2013 Jul; 43(7):263-70. PubMed ID: 23608595 [TBL] [Abstract][Full Text] [Related]
17. Long-term efficacy of a hepatitis E vaccine. Zhang J; Zhang XF; Huang SJ; Wu T; Hu YM; Wang ZZ; Wang H; Jiang HM; Wang YJ; Yan Q; Guo M; Liu XH; Li JX; Yang CL; Tang Q; Jiang RJ; Pan HR; Li YM; Shih JW; Ng MH; Zhu FC; Xia NS N Engl J Med; 2015 Mar; 372(10):914-22. PubMed ID: 25738667 [TBL] [Abstract][Full Text] [Related]
18. A truncated ORF2 protein contains the most immunogenic site on ORF2: antibody responses to non-vaccine sequences following challenge of vaccinated and non-vaccinated macaques with hepatitis E virus. Zhou YH; Purcell RH; Emerson SU Vaccine; 2005 May; 23(24):3157-65. PubMed ID: 15837215 [TBL] [Abstract][Full Text] [Related]
19. Hepatitis E vaccine: WHO position paper, May 2015--Recommendations. WHO Vaccine; 2016 Jan; 34(3):304-5. PubMed ID: 26232546 [TBL] [Abstract][Full Text] [Related]
20. Hepatitis E virus: Current epidemiology and vaccine. Wu X; Chen P; Lin H; Hao X; Liang Z Hum Vaccin Immunother; 2016 Oct; 12(10):2603-2610. PubMed ID: 27184971 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]